Biochemistry Terms Starting With X

Xanthine is an intermediate purine base produced during the breakdown of nucleic acids and found in most body tissues and fluids.

Xanthine forms when the enzyme xanthine oxidase converts hypoxanthine to xanthine, which is then oxidized to uric acid in the final step of purine degradation. In Dalmatian dogs, a genetic mutation affecting uric acid transporters causes xanthine to accumulate, leading to the formation of xanthine stones in the urinary tract. This pathway produces approximately 0.6 grams of uric acid daily in adult humans under normal dietary conditions, with xanthine serving as the penultimate intermediate before excretion.

Xanthine Oxidase is an enzyme that catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid during purine nucleotide degradation.

This molybdenum-containing enzyme is found primarily in the liver and small intestine, where it processes nitrogen-containing purine compounds. In humans, xanthine oxidase generates approximately 70% of the body’s total uric acid, with average daily production reaching 600 to 700 milligrams. Reactive oxygen species produced as byproducts of this reaction, including superoxide and hydrogen peroxide, can contribute to oxidative tissue damage when enzyme activity becomes chronically elevated, as occurs during ischemia-reperfusion injury.

Xenobiotic Metabolism is the biochemical process by which organisms transform foreign chemical compounds into more water-soluble products that can be excreted from the body.

The human liver processes thousands of different xenobiotics through specialized enzyme systems, primarily the cytochrome P450 superfamily, which comprises at least 57 functional genes in humans. Phase I reactions introduce or expose functional groups through oxidation, reduction, or hydrolysis, while Phase II reactions conjugate these groups with endogenous molecules such as glutathione or glucuronic acid to increase water solubility. Rainbow trout (Oncorhynchus mykiss) demonstrate a particularly high xenobiotic metabolism capacity, clearing certain pharmaceutical pollutants from water at rates exceeding 90% within 48 hours of exposure.

Xylitol is a five-carbon sugar alcohol derived from xylose that occurs as a natural metabolic intermediate in many organisms and is widely used as a low-calorie sweetener containing approximately 40% fewer calories than sucrose.

Humans produce small amounts of xylitol naturally during glucose metabolism, generating roughly 5 to 15 grams daily through the glucuronic acid pathway. The fungus Candida tropicalis accumulates xylitol when grown on xylose-rich media, making it a candidate organism for industrial xylitol biosynthesis. Commercial production relies primarily on chemical reduction of xylose extracted from birch bark or corn cobs, yielding a crystalline compound that resists fermentation by the oral bacteria Streptococcus mutans, which is why xylitol-sweetened gum reduces cavity formation.

Xylulose is a five-carbon ketose monosaccharide that exists in two isomeric forms and participates in carbohydrate metabolism as an intermediate in the pentose phosphate pathway.

D-xylulose appears as a key intermediate in the pentose phosphate pathway, where xylulokinase phosphorylates it to xylulose-5-phosphate. This phosphorylated form then enters reactions as a substrate for transketolase and transaldolase, reactions that generate precursors for nucleotide biosynthesis and regenerate NADPH for cellular reducing reactions. In humans, roughly 1 to 15% of dietary carbohydrates pass through the pentose phosphate pathway, with xylulose derivatives contributing to the production of ribose-5-phosphate needed for DNA and RNA synthesis.